PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
232.00
+4.00 (1.75%)
May 26, 2026, 4:00 PM WIB
Market Cap290.00B +45.0%
Revenue (ttm)171.06B +7.9%
Net Income3.35B
EPS2.68
Shares Out 1.25B
PE Ratio86.66
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume187,800
Open238.00
Previous Close228.00
Day's Range228.00 - 240.00
52-Week Range136.00 - 382.00
Beta0.59
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About IDX:DGNS

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology,... [Read more]

Sector Healthcare
Founded 2007
Employees 81
Stock Exchange Indonesia Stock Exchange
Ticker Symbol DGNS
Full Company Profile

Financial Performance

In 2025, IDX:DGNS's revenue was 166.62 billion, an increase of 2.18% compared to the previous year's 163.07 billion. Earnings were 2.94 billion, an increase of 292.95%.

Financial Statements